Logo image of BUD

ANHEUSER-BUSCH INBEV-SPN ADR (BUD) Stock Analyst Ratings

NYSE:BUD - New York Stock Exchange, Inc. - US03524A1088 - ADR - Currency: USD

68.35  -0.45 (-0.65%)

After market: 68.35 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to BUD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 80.67. This target is 18.03% above the current price.
BUD was analyzed by 33 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BUD.
In the previous month the buy percentage consensus was at a similar level.
BUD was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
BUD Historical Analyst RatingsBUD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 10 20 30

Price Target & Forecast

Price Low Median Mean High 68.3562.2579.5780.67148.44 - -8.92% 16.41% 18.03% 117.17%
BUD Current Analyst RatingBUD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-05-12 Goldman Sachs Upgrade Neutral -> Buy
2025-01-08 TD Cowen Maintains Hold -> Hold
2024-10-08 TD Cowen Downgrade Buy -> Hold
2024-10-01 Citigroup Upgrade Neutral -> Buy
2024-09-10 Morgan Stanley Maintains Overweight -> Overweight
2024-07-02 Morgan Stanley Maintains Overweight -> Overweight
2024-03-05 TD Cowen Maintains Outperform -> Outperform
2024-01-12 Exane BNP Paribas Downgrade Outperform -> Neutral
2024-01-10 Jefferies Upgrade Hold -> Buy
2023-11-29 JP Morgan Maintains Overweight -> Overweight
2023-09-29 B of A Securities Upgrade Neutral -> Buy
2023-07-20 Morgan Stanley Upgrade Equal-Weight -> Overweight
2023-06-22 Deutsche Bank Upgrade Hold -> Buy
2023-06-08 Evercore ISI Group Maintains Outperform
2021-11-19 Redburn Partners Upgrade Neutral -> Buy
2021-09-30 Argus Research Downgrade Buy -> Hold
2021-09-02 JP Morgan Downgrade Neutral -> Underweight